Advertisement

Natus Medical Incorporated NTUS

Set alert

Price alert · NTUS

All alert types
32.96 0.00 0.00%

As of Apr 24, 3:47 PM ET

32.84 Day range 33.07

52-week range unavailable

Open
32.90
Prev close
32.96
Mkt cap
1.14B
Vol
132.70K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
32.84
High
33.07
Forward P/E
20.99
Beta
0.23
Short ratio
4.11
Inst. own
95.20%
Dividend
0.00
Ex-div date
Earnings
Aug 4, 2022
50-d avg
32.61
200-d avg
27.38
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 4, 2021Earnings: —; estimate 0.3; surprise —%
  • Feb 24, 2022Earnings: —; estimate 0.44; surprise —%
  • May 5, 2022Earnings: —; estimate 0.26; surprise —%
Signals (25)
NameDateAgo
MACD: Buy SignalJul 19, 20224 years ago
MACD: Sell SignalJul 14, 20224 years ago
SMA: BullishJun 30, 20224 years ago
SMA: BearishJun 29, 20224 years ago
MACD: Buy SignalJun 27, 20224 years ago
SMA: BullishJun 24, 20224 years ago
SMA: BearishJun 22, 20224 years ago
SMA: BullishJun 21, 20224 years ago
SMA: BearishJun 16, 20224 years ago
RSI: OversoldJun 16, 20224 years ago
MACD: Sell SignalMay 5, 20224 years ago
MACD: Buy SignalApr 18, 20224 years ago
RSI: OverboughtApr 18, 20224 years ago
MACD: Sell SignalApr 5, 20224 years ago
MACD: Buy SignalMar 31, 20224 years ago
SMA: BullishMar 24, 20224 years ago
SMA: BearishMar 23, 20224 years ago
MACD: Sell SignalMar 10, 20224 years ago
RSI: OverboughtFeb 25, 20224 years ago
SMA: BullishFeb 22, 20224 years ago
MACD: Buy SignalFeb 10, 20224 years ago
MACD: Sell SignalJan 26, 20224 years ago
SMA: BearishJan 24, 20224 years ago
SMA: BullishJan 21, 20224 years ago
RSI: OversoldDec 1, 20214 years ago

Key statistics

Market cap
1.14B
Enterprise value
1.05B
Trailing P/E
86.74
Forward P/E
20.99
PEG ratio
1.04
Price / sales
2.38
Price / book
2.62
EPS (TTM)
0.38
Beta
0.23
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
2.65%
Revenue (TTM)
478.30M
Revenue growth
4.20%
Free cash flow
52.88M
Total cash
84.28M
Total debt
10.24M
Return on equity
3.02%
Shares outstanding
34.58M
Short % of float
6.11%
50-day average
32.61
200-day average
27.38

Analyst view

Consensus: hold

Hold
Price target (mean) 0.00

Next earnings

Aug 4, 2022

Expected Aug 4, 2022. Consensus EPS estimate 0.32.

Earnings history

Financials — quick view

All financials
NTUS Revenue — quarterly 119.79M
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
NTUS Net income — quarterly 1.90M
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
NTUS EPS — quarterly 0.06
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022

Earnings

NTUS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 4, 2022Jun 1, 20220.32———
May 5, 2022Mar 1, 20220.26———
Feb 24, 2022Dec 1, 20210.44———
Nov 4, 2021Sep 1, 20210.30———
Aug 5, 2021Jun 1, 20210.29———
May 6, 2021Mar 1, 20210.16———

Upgrades / downgrades

NTUS analyst upgrades and downgrades
DateFirmActionFromTo
Feb 2, 2017Raymond JamesdownOutperformMarket Perform
Oct 4, 2016Benchmarkinit—Buy
Sep 13, 2016Raymond JamesupMarket PerformOutperform
Apr 5, 2016Roth Capitalmain—Buy
Oct 7, 2014William BlairdownMarket PerformOutperform
May 6, 2013CJS Securitiesinit—Market Perform

About Natus Medical Incorporated

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
natus.com

News

Your note

Sign in to keep a note on NTUS — it syncs with the Stock Master app.

Insider holders

NTUS insider holders
InsiderRelationLatest transactionDateShares held
CHUNG DONG CHUNE CHRISTOPHEROfficerSaleDec 8, 202139,926
DASKAL ILANDirectorStock Award(Grant)Jun 14, 202218,937
DAVIES BENJAMIN DREWChief Financial OfficerStock Award(Grant)Jul 20, 20220
GUERIN ERICDirectorStock Award(Grant)Jun 14, 202210,114
HEINE LISA WIPPERMANDirectorStock Award(Grant)Jun 14, 202226,287
LEVINE JOSHUA HDirectorStock Award(Grant)Jun 14, 202237,387

Institution ownership

NTUS institution ownership
Holder% heldSharesValueReported
Blackrock Inc.18.82%6,506,467214.45MMar 30, 2022
Vanguard Group, Inc. (The)8.85%3,058,873100.82MMar 30, 2022
Victory Capital Management Inc.7.63%2,637,25486.92MMar 30, 2022
Allspring Global Investments Holdings, LLC6.06%2,096,94469.12MMar 30, 2022
Dimensional Fund Advisors LP4.04%1,398,69246.10MMar 30, 2022
State Street Corporation3.89%1,345,37444.34MMar 30, 2022

Fund ownership

NTUS fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF7.08%2,447,19480.66MJun 29, 2022
Victory Portfolios-Sycamore Small Company Opportunity Fund3.94%1,361,00044.86MApr 29, 2022
Janus Henderson Small Cap Value Fund3.23%1,115,72636.77MMar 30, 2022
Vanguard Total Stock Market Index Fund2.82%975,29332.15MMar 30, 2022
Allspring Special Small Cap Value Fund2.81%972,56732.06MMay 30, 2022
iShares Russell 2000 ETF2.26%780,12225.71MJun 29, 2022
Advertisement